mRNA Discovery Strategy Framework to Set You Up for Manufacturing Success

There is a robust and promising therapeutic pipeline of mRNA-based medicines. In this webcast, participants will learn how to implement discovery best practices to optimize the path to streamlined mRNA manufacturing. The discussion will include essential steps in establishing a robust process design, crucial for maintaining consistency and quality in mRNA manufacturing.

Register Free: https://www.pharmtech.com/pt/discovery-strategy-framework

Event Overview:

There is a robust and promising therapeutic pipeline of mRNA-based medicines. In this webcast, participants will learn how to implement discovery best practices to optimize the path to streamlined mRNA manufacturing. The discussion will include essential steps in establishing a robust process design, crucial for maintaining consistency and quality in mRNA manufacturing.

Key Learning Objectives:

• Implementing discovery best practices to set you up for streamlined manufacturing.
• Establishing your process design.
• Transferring your manufacturing strategy to clinical programs.

Who Should Attend:

Primary Audience: mRNA drug developers and professionals from biotechnology, emerging biopharma, and small to mid-sized pharma
Secondary Audience: mRNA professionals from higher education or academia
Job function: R&D, Process Development Scientists, Clinical Research and Supply, Clinical Operations, Quality Assurance, Procurement and Supply Chain

Speaker:

Linda Villa, PhD
Director of GMP Operations & Process Transfer
TriLink BioTechnologies

Dr Linda M. Villa is a director of GMP Operations and Process Transfer with TriLink Biotechnologies (part of Maravai). She joined the company in April of 2020 to build out the process development to GMP manufacturing customer pipeline. She currently leads GMP operations for the Nucleic Acid Services business unit at TriLink Biotechnologies.

Dr Villa has over 10 years of operations leadership experience, most recently leading operation teams such as Proteins, Fermentation, Quality Control and Vectors at Thermo Fisher Scientific. In addition to her operations experience, Dr Villa is a licensed Radiation Safety Officer. She helped build and manage the site’s radiation program alongside her EH&S colleagues. Dr Villa holds a BS in Molecular Cell and Biotechnology. She received her PhD from Virginia Tech in the field of molecular cell and protein biochemistry focused on breast cancer research. With a strong background in molecular biology and biochemistry, Dr Villa has a deep understanding of the complex processes involved in mRNA manufacturing. Throughout her career, Dr Villa has demonstrated exceptional leadership skills, successfully managing large teams of scientists to deliver high quality products. She has a proven track record of driving process improvements and optimizing manufacturing workflows to increase efficiency and reduce costs while promoting a safety driven culture.

Register Free: https://www.pharmtech.com/pt/discovery-strategy-framework